Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07512622 · ClinicalTrials.gov registry record · NA
Asthma Ctrl SMART Trial
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Not yet
- Registry status
- NA
- Development phase
- 389
- Enrollment target
NCT07512622: Clinical Trial NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT07512622 is a NA study that has not yet begun recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 389 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07512622, a NA study, has not yet begun recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 389 participants
- Enrollment target
Study Summary
The primary objective is to examine the efficacy of an mHealth adherence intervention (Asthma Ctrl) on adherence to daily inhaled corticosteroids as measured by electronically monitored adherence in adolescents with asthma. The secondary objective is to compare the effectiveness of three intervention strategies: 1. asthma management app (control); 2. Asthma Ctrl; 3. Asthma Ctrl+ on adherence, lung function, and health care utilization at post-intervention and 1- and 6-month follow-up. The third objective is to explore and contrast different challenges and combinations of challenges to identify which are most impactful in determining response to the three intervention strategies.
Primary Outcome
Monthly adherence rates will be calculated by dividing the number of doses recorded by the electronic monitor by the total number of prescribed doses; the rate is then multiplied by 100 to determine the percentage. For patients prescribed Single Maintenance and Reliever Therapy, per the new asthma guidelines, the study investigators will assume that initial doses taken are for prevention and adherence will be capped at 100%.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Asthma Ctrl
- BEHAVIORAL Asthma Ctrl+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 389 participants |
| Start Date | 2026-05-30 |
| Est. Completion | 2030-06-01 |
| Phase | NA |
What is known before NCT07512622 opens enrollment
NCT07512622 is an interventional study that assigns participants to a tested intervention. The registered 389 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT07512622 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07512622 about?
NCT07512622 is a clinical study titled "Asthma Ctrl SMART Trial". The primary objective is to examine the efficacy of an mHealth adherence intervention (Asthma Ctrl) on adherence to daily inhaled corticosteroids as measured by electronically monitored adherence in adolescents with asthma. The secondary objective is to compare the effectiveness of three interventio...
What is the current status of trial NCT07512622?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 389 participants. The study started on 2026-05-30. Estimated completion is 2030-06-01.
What interventions are being tested in trial NCT07512622?
The interventions under investigation include: Control (BEHAVIORAL), Asthma Ctrl (BEHAVIORAL), Asthma Ctrl+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT07512622?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07512622's enrollment target sits among peer trials
389 270th of 2000 higher than 1,731 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05431088 · 389 participants · Phase 2
A Phase 2/3 Study in Adult and Adolescent Participants With SCD
- NCT00397111 · 390 participants
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- NCT05335928 · 390 participants · Phase 3
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI